Boston Scientific | Advancing Science For Life

Investors

$14.2
billion FY 2023 sales
$2.05
adjusted EPS1 in 2023
$2.5
billion adjusted free cash flow1 in 2023

Events

Boston Scientific at Bernstein's 40th Annual Strategic Decisions Conference

May 29, 2024

Go to Events

ESG Resources

Environmental, Social, and Corporate Governance

Go to ESG Resources
Image for governance information

1 Non-GAAP measure; excludes certain GAAP items. For reconciliations of non-GAAP financial measures to the most directly comparable GAAP figures, please refer to our Financial Disclaimers and Non-GAAP Reconciliations.

Safe Harbor for forward-looking statements
This site contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like “anticipate,” “expect,” “project,” “believe,” “plan,” “estimate,” “intend” and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could differ materially from the expectations and projections expressed or implied by our forward looking statements.

Factors that may cause such differences can be found in our most recent Form 10-K and Forms 10-Q filed or to be filed with the Securities and Exchange Commission under the headings “Risk Factors” and “Safe Harbor for Forward-Looking Statements.” Accordingly, you are cautioned not to place undue reliance on any of our forward-looking statements. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which they may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.

Connect with Boston Scientific Investor Relations

Investor relations contact

300 Boston Scientific Way
Mailstop M405
Marlborough, MA 01752
BSXInvestorRelations@bsci.com